A Pharmacodynamic Study of the P-glycoprotein Antagonist CBT-1® in Combination With Paclitaxel in Solid Tumors.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Works matching IS 10837159 AND DT 2012 AND VI 17 AND IP 4
Results: 19
1
2
Agreement in Risk Prediction Between the 21-Gene Recurrence Score Assay (Oncotype DX®) and the PAM50 Breast Cancer Intrinsic Classifier™ in Early-Stage Estrogen Receptor-Positive Breast Cancer.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
3
European Perspectives: A Dialogue with the European Oncology Community.
- Published in:
- Oncologist, 2012, v. 17, n. 4, p. 1
- By:
- Publication type:
- Article
4
The Cardinal's Flight.
- Published in:
- 2012
- By:
- Publication type:
- Poem
5
Toward Individualized Breast Cancer Therapy: Translating Biological Concepts to the Bedside.
- Published in:
- Oncologist, 2012, v. 17, n. 4, p. 577, doi. 10.1634/theoncologist.2012-0032
- By:
- Publication type:
- Article
6
Time Course and Predictors for Cancer-Related Fatigue in a Series of Oropharyngeal Cancer Patients Treated with Chemoradiation Therapy.
- Published in:
- Oncologist, 2012, v. 17, n. 4, p. 569, doi. 10.1634/theoncologist.2011-0437
- By:
- Publication type:
- Article
7
Folliculitis Induced by EGFR Inhibitors, Preventive and Curative Efficacy of Tetracyclines in the Management and Incidence Rates According to the Type of EGFR Inhibitor Administered: A Systematic Literature Review.
- Published in:
- Oncologist, 2012, v. 17, n. 4, p. 555, doi. 10.1634/theoncologist.2011-0365
- By:
- Publication type:
- Article
8
Accumulating Evidence for a Drug-Interaction Between Methotrexate and Proton Pump Inhibitors.
- Published in:
- Oncologist, 2012, v. 17, n. 4, p. 550, doi. 10.1634/theoncologist.2011-0431
- By:
- Publication type:
- Article
9
Lapatinib for Advanced or Metastatic Breast Cancer.
- Published in:
- Oncologist, 2012, v. 17, n. 4, p. 536, doi. 10.1634/theoncologist.2011-0461
- By:
- Publication type:
- Article
10
Hypophysitis Induced by Monoclonal Antibodies to Cytotoxic T Lymphocyte Antigen 4: Challenges from a New Cause of a Rare Disease.
- Published in:
- Oncologist, 2012, v. 17, n. 4, p. 525, doi. 10.1634/theoncologist.2011-0404
- By:
- Publication type:
- Article
11
Bevacizumab-Based Therapies in the First-Line Treatment of Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2012, v. 17, n. 4, p. 513, doi. 10.1634/theoncologist.2012-0003
- By:
- Publication type:
- Article
12
A Pharmacodynamic Study of the P-glycoprotein Antagonist CBT-1 in Combination With Paclitaxel in Solid Tumors.
- Published in:
- 2012
- By:
- Publication type:
- Abstract
13
Trastuzumab for Small HER-2 + Breast Cancer: Small Tumor, Big Decision.
- Published in:
- 2012
- By:
- Publication type:
- Case Study
14
Tamoxifen Alters the Plasma Concentration of Molecules Associated with Cardiovascular Risk in Women with Breast Cancer Undergoing Chemotherapy.
- Published in:
- Oncologist, 2012, v. 17, n. 4, p. 499, doi. 10.1634/theoncologist.2011-0369
- By:
- Publication type:
- Article
15
Agreement in Risk Prediction Between the 21-Gene Recurrence Score Assay (Oncotype DX) and the PAM50 Breast Cancer Intrinsic Classifier™ in Early-Stage Estrogen Receptor-Positive Breast Cancer.
- Published in:
- Oncologist, 2012, v. 17, n. 4, p. 492, doi. 10.1634/theoncologist.2012-0007
- By:
- Publication type:
- Article
16
The Impact of Diabetes Mellitus on Prognosis of Early Breast Cancer in Asia.
- Published in:
- Oncologist, 2012, v. 17, n. 4, p. 485, doi. 10.1634/theoncologist.2011-0412
- By:
- Publication type:
- Article
17
Capecitabine Monotherapy: Review of Studies in First-Line HER-2-Negative Metastatic Breast Cancer.
- Published in:
- Oncologist, 2012, v. 17, n. 4, p. 476, doi. 10.1634/theoncologist.2011-0281
- By:
- Publication type:
- Article
18
Phase II Study of Bevacizumab in Combination with Trastuzumab and Capecitabine as First-Line Treatment for HER-2-positive Locally Recurrent or Metastatic Breast Cancer.
- Published in:
- Oncologist, 2012, v. 17, n. 4, p. 469, doi. 10.1634/theoncologist.2011-0344
- By:
- Publication type:
- Article
19
Communicating About Phase I Trials: Objective Disclosures Are Only A First Step.
- Published in:
- 2012
- By:
- Publication type:
- Editorial